Evidence Corner
Welcome to Evidence Corner. Here we try to explain the data behind the clinical decisions we make through deep-diving studies that have shaped how we treat patients with liver disease. For each clinical question, we’ve chosen a single study and with our digestible slides, we try to concisely highlight the key aspects of the study.
Current Team
Fellow Lead
Faculty Editor
Evidence CornerCan plasma ammonia levels predict hospitalizations for liver-related complications in outpatients with cirrhosis?
Is plasma ammonia a useless biomarker?
Sarah KhanEvidence CornerDoes aspirin prophylaxis post-liver transplant reduce risk of hepatic artery thrombosis?
Could this be yet another benefit of aspirin use?
Media IsmaelEvidence CornerCan Diabetic Medications and Glycemic Control Affect the Incidence of HCC in Patients with NAFLD?
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.32244 More benefits of good glycemic control in patients with NAFLD!
Chiara MaruggiEvidence CornerCan ECGs be used to identify cirrhosis?
https://pubmed.ncbi.nlm.nih.gov/35029163/ Turns out, ECGs aren’t just for the heart!
Muyi LiEvidence CornerSCOPE Index
How does one prognosticate outcomes in pediatric primary sclerosing cholangitis? https://pubmed.ncbi.nlm.nih.gov/32464706/
Kayla Hartjes
Sindhu PandurangiEvidence CornerMedical Therapy for NASH: The PIVENS Trial
Are there any treatment options for medical management of NASH? Find out in this summary of the PIVENS Trial!
Richie ManikatEvidence CornerDoes low vitamin D level correlate with risk of hepatic decompensation?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224127/ Can a simple, inexpensive supplement decrease risk of liver decompensation?
Media IsmaelEvidence CornerDo Steroids Improve Outcomes After Kasai Hepatoportoenterostomy
https://jamanetwork.com/journals/jama/fullarticle/1866094
Alvin ChanEvidence CornerDoes rifaximin prevent hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS)?
Hepatic encephalopathy after TIPS is common. So how do we prevent it?
Muyi LiEvidence CornerCan COVID-19 vaccination improve outcomes for patients with chronic liver disease or post-liver transplant in those who contract the infection?
Learn how covid-19 vaccination affects outcomes in patients with liver disease
Chiara MaruggiCurrent Team
Fellow Lead
Faculty Editor
Ideas?
Do you have suggestions for topics within this series? Are you a fellow interested in contributing? Please feel free to reach out via Twitter to the fellow lead or to Liver Fellow Network directly. You can also e-mail us at liverfellownetwork@gmail.com.